31 completed, 5 unknown, 1 active not recruiting, 1 terminated. 13 Phase 4, 9 Phase 2, 8 Phase 3, 6 Not applicable, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 10, Unknown 3 |
| Phase 2 | 9 | Completed 8, Active not recruiting 1 |
| Phase 3 | 8 | Completed 8 |
| Not applicable | 6 | Completed 2, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 3 |
Follow MoviPrep: new trials by email Literature Review of MoviPrep trials Research Report on MoviPrep
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life Plenvu, Moviprep - Colorectal Cancer, Colonic Polyp | Not applicable | Completed | Radboud University Medical Center | 509 | 2022-05-16 | 2024-11-21 |
| Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma MaaT013, Ipilimumab, Nivolumab - Melanoma | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 70 | 2022-01-20 | 2025-08-28 |
| MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy MoviPrep, Golytely - Bowel Preparation Before Colonoscopy | Phase 4 | Completed | Yale University | 520 | 2022-01-12 | 2026-03-11 |
| Preparation Regimens to Improve Capsule Endoscopy Visualization and Diagnostic Yield Moviprep - Obscure Gastrointestinal Bleeding | Not applicable | Unknown | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 210 | 2021-12-01 | 2021-12-01 |
| Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients NER1006, MoviPrep, Macrogol 400 - Colon Disease | Phase 4 | Unknown | University of Bologna | 846 | 2021-02-01 | 2021-01-13 |
| Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep® Phase II: NTC015 low dose, Phase II: NTC015 medium dose, Phase II: NTC015 high dose - Elective Colonoscopy | Phase 2 / Phase 3 | Completed | NTC srl | 886 | 2020-06-18 | 2025-12-08 |
| The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy Eziklen®, MoviPrep - Colorectal Disorders | Not applicable | Unknown | Russian Society of Colorectal Surgeons | 98 | 2019-06-02 | 2020-05-19 |
| 1L-PEG-Asc Solution for Bowel Preparation in an "Open Access" Colonoscopy Booking System: Evaluation of Adverse Events use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy - Bowel Preparation | Completed | Azienda USL Modena | 5981 | 2019-01-01 | 2022-03-03 | |
| Comparison of Two Preparations for the Study of the Colon Through Colonoscopy PLENVU, MoviPrep - Colon Cancer, Colon Polyp | Completed | Unidade Local de Saúde do Alto Ave, EPE | 613 | 2019-01-01 | 2020-08-04 | |
| Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients Sodium Picosulfate/Magnesium Citrate Laxative, 2L polyethylene glycol/ascorbic acid - Ulcerative Colitis | Phase 4 | Unknown | American University of Beirut Medical Center | 68 | 2018-03-26 | 2019-09-19 |
| Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders Vancomycin, MoviPrep, Full Spectrum Microbiota - Autism Spectrum Disorder, Gastrointestinal Disorder | Phase 2 | Active not recruiting | Arizona State University | 55 | 2018-01-04 | 2023-01-09 |
| Safety and Efficacy Study of an Edible Colonoscopy Preparation ECP Colon Prep Kit, MoviPrep® - Colon Prep for Colonoscopy | Phase 2 | Completed | Sebela Pharmaceuticals Development LLC | 60 | 2017-11-20 | 2018-03-19 |
| Safety and Tolerability Study of an Edible Colon Preparation NuLYTELY® (PEG 3350), ECP-019, MoviPrep® (PEG 3350) - Bowel Preparation | Phase 2 | Completed | ColonaryConcepts LLC | 69 | 2015-05-01 | 2018-01-29 |
| Safety and Efficacy of CDFR0612 and CDFR0613 for Bowel Cleansing Before Colonoscopy CDFR0612, CDFR0613, Coolprep Powder - Colonoscopy Preparation, Colon Disease | Phase 3 | Completed | CTC Bio, Inc. | 310 | 2015-01-01 | 2015-09-11 |
| Improvement of Tolerance of Bowel Cleansing Before Colonoscopy in Diabetic Patients PEG-ascorbate 2L, PEG 4L - Diabetes Mellitus, Colonic Diseases | Phase 3 | Completed | Parc de Salut Mar | 158 | 2014-12-02 | 2017-02-23 |
| Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. NER1006, 2-Day Split-Dosing, NER1006,1-Day Morning Split-Dosing, MOVIPREP, 2-Day Split-Dosing - Colorectal Cancer, Colorectal Carcinoma | Phase 3 | Completed | Norgine | 849 | 2014-10-01 | 2018-05-15 |
| Beneficial Bacteria Treatment for Autism oral Vancomycin, MoviPrep, Prilosec - Gastrointestinal Problems, Autism Spectrum Disorders | Phase 1 / Phase 2 | Completed | Arizona State University | 18 | 2014-07-01 | 2025-09-12 |
| Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy PEG+E, PEG+Asc, P+MC - Patients Undergoing Screening or Surveillance Colonoscopy | Not applicable | Withdrawn | Medical College of Wisconsin | 2014-06-01 | 2015-07-10 | |
| The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies Low volume prep (Prepopik), Moderate volume prep (Moviprep), High volume prep (Golytely) - Colonoscopy | Not applicable | Terminated | Mayo Clinic | 32 | 2013-09-01 | 2020-07-17 |
| 2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation Polyethylene Glycol (PEG) and 15 mg Bisacodyl, Polyethylene Glycol (PEG) + ascorbic acid - Colonoscopy | Phase 4 | Completed | University of British Columbia | 309 | 2013-04-01 | 2016-06-20 |
Showing 20 of 39. Sign in to see all of them.
Colorectal Neoplasms (6) · Colonic Diseases (3) · Autism Spectrum Disorder (2) · Colonic Neoplasms (2) · Colonic Polyps (2) · Gastrointestinal Diseases (2) · Colitis, Ulcerative (1) · Diabetes Mellitus (1) · Hyponatremia (1) · Melanoma (1) · Mucopolysaccharidosis IV (1) · Personal Satisfaction (1)
Norgine (11) · American University of Beirut Medical Center (2) · Arizona State University (2) · ASST Fatebenefratelli Sacco (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Policlinico Umberto I (1) · Azienda USL Modena (1) · CTC Bio, Inc. (1) · Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. (1) · ColonaryConcepts LLC (1) · Gastroenterology Services, Ltd. (1) · Mayo Clinic (1) · Medical College of Wisconsin (1) · NTC srl (1) · Parc de Salut Mar (1)
United States (8) · Germany (7) · Italy (7) · France (5) · United Kingdom (4) · Russia (3) · Belgium (2) · Lebanon (2) · Portugal (2) · Spain (2) · Canada (1) · Kazakhstan (1) · Netherlands (1) · Poland (1) · Romania (1)
Christian Ell, Prof Dr med (2) · James B Adams, PhD (2) · Ala I Sharara, Prof (1) · Alain Bitoun, MD (1) · Alessandro Repici, MD (1) · Andrey Kiryukhin (1) · Angelo Andriulli, MD (1) · Cesare Hassan, MD (1) · Ching Lam, MBChB MRCP (1) · Darrick K Li, MD, PhD (1) · David Gerard, MD (1) · David Kastenberg, MD (1) · Dongjin Yoo, M.D. (1) · Fayez S Sarkis, MD (1) · Francisco Ramirez, MD (1)
PMID 18179734, PMID 18190651, PMID 25066025, PMID 25180609, PMID 25684963, PMID 25950434, PMID 27433812, PMID 28122648, PMID 30025414, PMID 30967657, PMID 31146679, PMID 32660521, PMID 33087514, PMID 36064325, PMID 36799346, PMID 40786127, PMID 41128725, PMID 42081822
2019 (1)